CME Group Buys CMA for OTC Data Play

The acquisition, which closed on Sunday, March 23, "diversifies the CME as a company, and gives us exposure to the large and fast-growing OTC derivatives market... [where] we can add value in terms of leveraging our technology and transaction processing capabilities," says a CME spokesperson.

CME participants "are looking for tools like [those of] CMA that help them make better trading decisions" in the credit markets, which remain relatively opaque, the spokesperson says. "This is another area

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Waterstechnology? View our subscription options

Register for free

Access two articles, our IMD and Waters Wraps, plus a member newsletter. Find out more.

All fields are mandatory unless otherwise highlighted.

Most read articles loading...

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here